Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
ISTH guidelines for treatment of thrombotic thrombocytopenic purpuraZheng, X. Long ; Vesely, Sara K. ; Cataland, Spero R. ; Coppo, Paul ; Geldziler, Brian ; Iorio, Alfonso ; Matsumoto, Masanori ; Mustafa, Reem A. ; Pai, Menaka ; Rock, Gail ; Russell, Lene ; Tarawneh, Rawan ; Valdes, Julie ; Peyvandi, FloraJournal of thrombosis and haemostasis, 2020-10, Vol.18 (10), p.2496-2502 [Periódico revisado por pares]Texto completo disponível |
2 |
Material Type: Artigo
|
![]() |
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trialJoly, Pascal, Professor ; Maho-Vaillant, Maud, PhD ; Prost-Squarcioni, Catherine, Prof ; Hebert, Vivien, MD ; Houivet, Estelle, MS ; Calbo, Sébastien, PhD ; Caillot, Frédérique, PhD ; Golinski, Marie Laure, PhD ; Labeille, Bruno, Prof ; Picard-Dahan, Catherine, MD ; Paul, Carle, Prof ; Richard, Marie-Aleth, Prof ; Bouaziz, Jean David, Prof ; Duvert-Lehembre, Sophie, MD ; Bernard, Philippe, Prof ; Caux, Frederic, Prof ; Alexandre, Marina, MD ; Ingen-Housz-Oro, Saskia, MD ; Vabres, Pierre, Prof ; Delaporte, Emmanuel, Prof ; Quereux, Gaelle, Prof ; Dupuy, Alain, Prof ; Debarbieux, Sebastien, MD ; Avenel-Audran, Martine, MD ; D'Incan, Michel, Prof ; Bedane, Christophe, Prof ; Bénéton, Nathalie, MD ; Jullien, Denis, Prof ; Dupin, Nicolas, Prof ; Misery, Laurent, Prof ; Machet, Laurent, Prof ; Beylot-Barry, Marie, Prof ; Dereure, Olivier, Prof ; Sassolas, Bruno, MD ; Vermeulin, Thomas, MD ; Benichou, Jacques, Prof ; Musette, Philippe, ProfThe Lancet (British edition), 2017-05, Vol.389 (10083), p.2031-2040 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trialPoeschel, Viola ; Held, Gerhard ; Ziepert, Marita ; Witzens-Harig, Mathias ; Holte, Harald ; Thurner, Lorenz ; Borchmann, Peter ; Viardot, Andreas ; Soekler, Martin ; Keller, Ulrich ; Schmidt, Christian ; Truemper, Lorenz ; Mahlberg, Rolf ; Marks, Reinhard ; Hoeffkes, Heinz-Gert ; Metzner, Bernd ; Dierlamm, Judith ; Frickhofen, Norbert ; Haenel, Mathias ; Neubauer, Andreas ; Kneba, Michael ; Merli, Francesco ; Tucci, Alessandra ; de Nully Brown, Peter ; Federico, Massimo ; Lengfelder, Eva ; di Rocco, Alice ; Trappe, Ralf ; Rosenwald, Andreas ; Berdel, Christian ; Maisenhoelder, Martin ; Shpilberg, Ofer ; Amam, Josif ; Christofyllakis, Konstantinos ; Hartmann, Frank ; Murawski, Niels ; Stilgenbauer, Stephan ; Nickelsen, Maike ; Wulf, Gerald ; Glass, Bertram ; Schmitz, Norbert ; Altmann, Bettina ; Loeffler, Markus ; Pfreundschuh, MichaelThe Lancet (British edition), 2019-12, Vol.394 (10216), p.2271-2281 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)Sharman, Jeff P. ; Liberati, Anna Marina ; Ishizawa, Kenichi ; Khan, Tahira ; Robbins, Jeffery ; Alcasid, Ann ; Rosenberg, Julie Ann ; Aurer, IgorBioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-04, Vol.34 (2), p.171-181 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsEbbo, Mikael ; Grados, Aurélie ; Samson, Maxime ; Groh, Matthieu ; Loundou, Anderson ; Rigolet, Aude ; Terrier, Benjamin ; Guillaud, Constance ; Carra-Dallière, Clarisse ; Renou, Frédéric ; Pozdzik, Agnieszka ; Labauge, Pierre ; Palat, Sylvain ; Berthelot, Jean-Marie ; Pennaforte, Jean-Loup ; Wynckel, Alain ; Lebas, Céline ; Le Gouellec, Noémie ; Quémeneur, Thomas ; Dahan, Karine ; Carbonnel, Franck ; Leroux, Gaëlle ; Perlat, Antoinette ; Mathian, Alexis ; Cacoub, Patrice ; Hachulla, Eric ; Costedoat-Chalumeau, Nathalie ; Harlé, Jean-Robert ; Schleinitz, Nicolas Weber, Martin SebastianPloS one, 2017-09, Vol.12 (9), p.e0183844-e0183844 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimensWang, Hsiao-Han ; Liu, Che-Wei ; Li, Yu-Chuan ; Huang, Yu-ChenActa dermato-venereologica, 2015-11, Vol.95 (8), p.928-932 [Periódico revisado por pares]SwedenTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
ISTH guidelines for treatment of thrombotic thrombocytopenic purpuraZheng, X. Long ; Vesely, Sara K. ; Cataland, Spero R. ; Coppo, Paul ; Geldziler, Brian ; Iorio, Alfonso ; Matsumoto, Masanori ; Mustafa, Reem A. ; Pai, Menaka ; Rock, Gail ; Russell, Lene ; Tarawneh, Rawan ; Valdes, Julie ; Peyvandi, FloraJournal of thrombosis and haemostasis, 2020-10, Vol.18 (10), p.2496-2502 [Periódico revisado por pares]England: Wiley Subscription Services, IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapyApostolidis, Sokratis A ; Kakara, Mihir ; Painter, Mark M ; Goel, Rishi R ; Mathew, Divij ; Lenzi, Kerry ; Rezk, Ayman ; Patterson, Kristina R ; Espinoza, Diego A ; Kadri, Jessy C ; Markowitz, Daniel M ; E Markowitz, Clyde ; Mexhitaj, Ina ; Jacobs, Dina ; Babb, Allison ; Betts, Michael R ; Prak, Eline T Luning ; Weiskopf, Daniela ; Grifoni, Alba ; Lundgreen, Kendall A ; Gouma, Sigrid ; Sette, Alessandro ; Bates, Paul ; Hensley, Scott E ; Greenplate, Allison R ; Wherry, E John ; Li, Rui ; Bar-Or, AmitNature medicine, 2021-11, Vol.27 (11), p.1990-2001 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm StudyHaridas, Vikram Muralidhar ; Katta, Rahul ; Nalawade, Ajit ; Kharkar, Sandeep ; Zhdan, Vyacheslav ; Garmish, Olena ; Lopez-Lazaro, Luis ; Batra, Sonica Sachdeva ; Kankanwadi, SureshBioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-04, Vol.34 (2), p.183-196 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Lenalidomide, rituximab (R 2 ), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphomaHill, Brian T ; Chen, Yanwen ; Jagadeesh, Deepa ; Dean, Robert ; Koc, Omer ; Boughan, Kirsten ; Cooper, Brenda ; Pohlman, Brad ; Caimi, Paolo ; Smith, Mitchell RLeukemia & lymphoma, 2024-06, Vol.65 (6), p.768-773 [Periódico revisado por pares]United StatesTexto completo disponível |